Lowering Costs for Patients: The Health of the Biosimilar Market

Scheduled · Apr 8, 2025, 2:00 PM

Type: Hearing
Committees: House Ways and Means Subcommittee on Health
Room: 1100
Building: Longworth House Office Building

Related bills

No related bill details are available for this meeting yet.

Witnesses

Dr. Debra Patt President · Community Oncology Alliance
Dr. Colin Edgerton Director · Articularis Healthcare Group
Craig Burton Executive Director · Biosimilars Council
Dr. Aaron Kesselheim Professor of Medicine · Harvard University